SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-023041
Filing Date
2020-12-07
Accepted
2020-12-07 16:32:20
Documents
2
Period of Report
2020-12-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2257
2 ex24.htm EX-24 10207
  Complete submission text file 0001493152-20-023041.txt   13946
Mailing Address C/O QUALIGEN THERAPEUTICS, INC. 2042 CORTE DEL NOGAL CARLSBAD CA 92011
Business Address
EMERY SIDNEY W JR (Reporting) CIK: 0001183148 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37428 | Film No.: 201373097

Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations